What You Should Know:
- The latest edition of SVB's Healthcare Investments and Exits report provides information on VC fundraising, investments and M&A and IPO trends - along with subsector analysis and video commentary for each.
- Healthcare trends indicate US healthcare VC investment was healthy in 2022 despite an economic downturn. There's plenty of dry powder to deploy; however, investments and exits are slowing due to the volatile market.
Trends and Insights – Healthcare
Read More
Most Popular
M&A: LeanTaaS Acquires Hospital IQ, Combined Valuation Exceeds $1B
What You Should Know:
- LeanTaaS, Inc., a provider of AI-powered and SaaS-based capacity management and patient flow software for health systems, today announced it has acquired Hospital IQ, a provider of intelligent automation solutions for hospitals. The acquisition values the combined company at more than $1 billion in enterprise value and enables it to power intelligent operations across more than 180+ U.S. health systems. The financial terms of the acquisition were not disclosed.
-
Read More
6 Executive Health Data Predictions to Watch in 2023
Kevin Agatstein, CEO at Kaid Health
In 2023 I predict that unstructured medical data, which makes up the majority of a patient’s chart, will become too valuable to ignore by both providers and payers. Driven in part by the growth of Medicare Advantage and oncology, both of which require the data within medical notes rather than just claims and labs data, organizations will start to use their unstructured EMR data in entirely new ways.
Rob Cohen, CEO at Bamboo Health
In today’s
Read More
The Patient Journey Tech Stack: 10 Pharma Predictions for 2023
The complexity of demands on Market Access teams has increased in recent years, between introducing innovative therapies targeting smaller populations and higher bars from Payers and PBMs.
Now, drug manufacturers are bucking up. According to the IQVIA Institute, the prescription abandonment rate has reached 27 percent, or $76 billion annually, in specialty drugs alone. This squandered revenue has led manufacturers to increase their focus on the complex, nuanced patient journey.
As a
Read More
7 Buy-Side Considerations for Healthcare M&A in 2023
The shift to value-based care and an abundance of cash in the market are some of the drivers impacting healthcare mergers and acquisitions. These and other trends have been strong over the past few months and are expected to continue, impacting transaction planning for buyers.
If you are considering acquiring a healthcare business in 2023, here are seven things you need to know.
1. Value-based care is becoming a key driver in healthcare M&A
Value-based care
Read More
Q/A: Podimetrics CEO Talks Preventing Diabetic Amputations
Diabetes prevention is one of the biggest challenges in the healthcare industry as more than 37 million Americans (11.3% of the population) suffer from this debilitating chronic disease. As we close the year out, we sat down with Jon Bloom, MD, CEO and Co-founder of diabetic healthcare tech company Podimetrics to learn how the industry and his company are working to implement health equity change to serve patients living with advanced diabetes. The company’s FDA-cleared SmartMat provides a
Read More
Healthcare Executives Are Burned Out; Here’s What to Do About It
What You Should Know:
- In the summer of 2022, WittKieffer emailed an online survey to thousands of healthcare C-suite executives of a range of titles at leading hospitals, health systems, academic medical centers, medical groups and other provider organizations. The survey asked questions about feelings of burnout in leaders’ lives and at work as well as the professional impact of the global pandemic.
- A total of 233 healthcare executives, including 63 CEOs, completed the survey. Of
Read More
BehaVR & Oxford VR Merge, Raises $13M for VR Delivery Platform
What You Should Know:
- Virtual reality mental and behavioral health companies BehaVR and OxfordVR today announced their merger, supported by an initial $13M in Series B funding led by Optum Ventures and Oxford Science Enterprises, with participation from Confluent Health, Accenture Ventures, Chrysalis Ventures and Thornton Capital.
- Uniting under the BehaVR brand, digital therapeutic companies BehaVR and OxfordVR will deliver comprehensive virtual reality-based treatments for mental and
Read More
Analysis: RSNA 2022: Predictions vs Reality
Much has already been written about attendance at RSNA, but from a first-hand perspective, RSNA 2022 could be regarded as a step back toward “normal”. Amongst mostly bustling halls, vendors reported very positive feedback on the volume and quality of customer meetings, with one prominent global imaging vendor citing “We’re signing deals here at the show again – things are looking up”.
Against this positive backdrop, however, the stark challenges facing radiology in a post-COVID world were
Read More
How My Telehealth Company Used Revenue-Based Financing – not VC – to Get Mental Health Services to Underserved Seniors
Beyond just the impact of COVID-19, the need for tele-mental healthcare and telepsychiatry services continues to expand, especially for rural communities. With the unpredictable venture capital market, startups offering telehealth services increasingly find themselves evaluating alternative financing options.
I’ve noticed a number of alternatives have emerged in the last several years. These can be especially helpful for startups that need quick decisions and have predictable revenue growth
Read More